These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1837981)

  • 1. Effects of toremifene and its main metabolites on growth of breast cancer cell lines.
    Coradini D; Biffi A; Cappelletti V; Di Fronzo G
    Anticancer Res; 1991; 11(6):2191-7. PubMed ID: 1837981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiestrogenic and DNA damaging effects induced by tamoxifen and toremifene metabolites.
    Liu X; Pisha E; Tonetti DA; Yao D; Li Y; Yao J; Burdette JE; Bolton JL
    Chem Res Toxicol; 2003 Jul; 16(7):832-7. PubMed ID: 12870885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of different combinations of tamoxifen and toremifene on estrogen receptor-positive breast cancer cell lines.
    Coradini D; Biffi A; Cappelletti V; Di Fronzo G
    Cancer Detect Prev; 1995; 19(4):348-54. PubMed ID: 7553677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cytotoxicity of tamoxifen and its principal metabolites in human breast cancer cell lines].
    Bachmann-Moisson N; Barberi-Heyob M; Merlin JL; Ledrich ML; Batt AM; Guillemin F
    Bull Cancer; 1996 Oct; 83(10):808-15. PubMed ID: 8952630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clusterin: a potential target for improving response to antiestrogens.
    Toffanin S; Daidone MG; Miodini P; De Cecco L; Gandellini P; Cappelletti V
    Int J Oncol; 2008 Oct; 33(4):791-8. PubMed ID: 18813793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential sensitivity of human breast cancer cell lines to the growth-inhibitory effects of tamoxifen.
    Reddel RR; Murphy LC; Hall RE; Sutherland RL
    Cancer Res; 1985 Apr; 45(4):1525-31. PubMed ID: 3978620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toremifene enhances cell cycle block and growth inhibition by vinblastine in multidrug resistant human breast cancer cells.
    Baker WJ; Maenpaa JU; Wurz GT; Koester SK; Seymour RC; Emshoff VD; Wiebe VJ; DeGregorio MW
    Oncol Res; 1993; 5(6-7):207-12. PubMed ID: 8123940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytostatic and cytotoxic action of Z-1, 1-dichloro-2,3-diphenylcyclopropane in three human breast cancer cell lines.
    ter Haar E; Day BW
    Anticancer Res; 1996; 16(3A):1107-15. PubMed ID: 8702221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiestrogenic action of toremifene on hormone-dependent, -independent, and heterogeneous breast tumor growth in the athymic mouse.
    Robinson SP; Jordan VC
    Cancer Res; 1989 Apr; 49(7):1758-62. PubMed ID: 2522347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationale for sequential tamoxifen and anticancer drugs in adjuvant setting for patients with node- and receptor-positive breast cancer.
    Kim R; Tanabe K; Emi M; Uchida Y; Osaki A; Toge T
    Int J Oncol; 2005 Apr; 26(4):1025-31. PubMed ID: 15753998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tocotrienols inhibit growth of ZR-75-1 breast cancer cells.
    Nesaretnam K; Dorasamy S; Darbre PD
    Int J Food Sci Nutr; 2000; 51 Suppl():S95-103. PubMed ID: 11271861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Combined effects of toremifene and paclitaxel on human breast cancer cell lines].
    Maruyama S; Kuroiwa S; Saimoto A; Nishikawa K
    Gan To Kagaku Ryoho; 2003 May; 30(5):669-75. PubMed ID: 12795099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of pharmacological concentrations of estrogens on proliferation and cell cycle kinetics of human breast cancer cell lines in vitro.
    Reddel RR; Sutherland RL
    Cancer Res; 1987 Oct; 47(20):5323-9. PubMed ID: 3652038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of human breast cancer cell proliferation in tissue culture by the neuroleptic agents pimozide and thioridazine.
    Strobl JS; Kirkwood KL; Lantz TK; Lewine MA; Peterson VA; Worley JF
    Cancer Res; 1990 Sep; 50(17):5399-405. PubMed ID: 2386945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tamoxifen and beta-interferon: effect of simultaneous or sequential treatment on breast cancer cell lines.
    Coradini D; Biffi A; Pirronello E; Di Fronzo G
    Anticancer Res; 1995; 15(2):315-9. PubMed ID: 7763000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiproliferative effect of leuprorelin acetate, alone or combined with tamoxifen or medroxyprogesterone acetate, on human breast cancer cell lines.
    Sica G; Iacopino F; Marini L; Robustelli della Cuna G
    Clin Ther; 1992; 14 Suppl A():87-96. PubMed ID: 1535023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells.
    Miller MA; Lippman ME; Katzenellenbogen BS
    Cancer Res; 1984 Nov; 44(11):5038-45. PubMed ID: 6488162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of human breast cancer cell proliferation with estradiol metabolites is as effective as with tamoxifen.
    Seeger H; Huober J; Wallwiener D; Mueck AO
    Horm Metab Res; 2004 May; 36(5):277-80. PubMed ID: 15156405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-steroid receptor-mediated antiproliferative activity of styrylpyrone derivative in human breast cancer cell lines.
    Pihie AH; Stanslas J; Din LB
    Anticancer Res; 1998; 18(3A):1739-43. PubMed ID: 9673398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of tamoxifen and the derivative (TAT) on cell cycle of MCF-7 in vitro.
    Tominaga T; Yoshida Y; Matsumoto A; Hayashi K; Kosaki G
    Anticancer Res; 1993; 13(3):661-5. PubMed ID: 8317894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.